ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• How Modern Platforms Enable Connected Clinical Data Systems And Flexible Study Workflows

  Digital trials demand seamless data flow. APIs reduce manual work, improve oversight, and power flexible, connected study environments.

• The New Standard In Participant-Centric Trials

  Clinical technology must serve both scientific rigor and human experience—and Castor is positioning itself at the forefront of this participant-led future.

• Patient Caregiver Network Improves Post-Seizure Trial Data

  Discover how a pharmaceutical CRO addressed concerns about seizure diary timing in a rare disease study, leveraging insights from Medable's Patient Community Network to optimize data collection.

• Letter From The CEO: A New Era Of Drug Development Is Here

  This letter from Medable CEO Michelle Longmire lays out why we created Studio, what it enables sponsors and CROs to do, and how it will help everyone bring more effective therapies to patients faster.

• IRT: A New Approach To Meeting The Needs Of Early Phase Trials

  As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.

• Benefits Of Using ePRO In Early Phase Studies

  Discover how harnessing Patient Reported Outcomes electronically in early-phase trials can boost patient centricity, create more cost-effective operations, and help generate better data faster.

• Building A Competitive Advantage With EDC

  Discover how an EDC platform that was flexible and easy to use was able to help a CRO build the most attractive offerings possible for their customers.

• AI's Bottleneck In Clinical Trials Moved, And Most People Missed It

  AI has accelerated drug discovery, but the real bottleneck is now clinical trial operations. Explore why regulatory success depends on auditable data governance, not model speed.

• Responsible Use Of AI In Healthcare: Work In Progress

  Delve into the transformative role and potential benefits of artificial intelligence (AI) in healthcare and learn why it's crucial to carefully consider and plan for the responsible use of AI.

• The FDA's Remote Regulatory Assessments: The Future Of Inspections

  Remote Regulatory Assessments (RRAs) provide distinct advantages over traditional inspections, such as increased efficiency, reduced travel costs, and enhanced global oversight capabilities.